Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Antengene Announces First Patient Dosed of Small Molecule ATR ATG-018 for the Treatment of Patients with Advanced Solid Tumors and Hematologic Malignancies in Australia 2022-08-16 08:30
Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877 2022-08-16 08:17
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories 2022-08-16 07:15
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud 2022-08-15 07:00
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17 2022-08-12 21:39
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma. 2022-08-12 10:13
WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology 2022-08-12 09:09
Everest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in Taiwan 2022-08-11 08:00
Panacell Biotech to conduct toxicity tests for NK cells, exosomes, and brown adipose-derived stem cells to treat patients with long COVID 2022-08-10 22:00
WeTrade Group Entered Into A Strategic Partnership With Jiqing, Acquiring Monkeypox Test Kits Exclusive Sales Channel 2022-08-10 20:36
Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine 2022-08-10 16:06
Starpharma signs new DEP® agreement with MSD 2022-08-10 15:29
Bridge Biotherapeutics Presents Promising Interim Clinical Study Results from Phase 1 Study of BBT-176 at WCLC 2022 2022-08-10 11:43
MedAlliance SELUTION SLR Receives Second FDA IDE Approval 2022-08-10 10:00
iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform 2022-08-10 09:00
Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth 2022-08-09 21:17
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform 2022-08-09 20:00
Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol® 2022-08-09 19:00
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in China 2022-08-09 17:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-004 2022-08-09 12:00
1 122 123 124 125 126 415